X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2305) 2305
virology (1361) 1361
animals (1255) 1255
hiv-1 - immunology (1221) 1221
immunology (1138) 1138
gene products, env - immunology (900) 900
hiv (899) 899
hiv-1 - genetics (898) 898
viruses (858) 858
infectious diseases (832) 832
molecular sequence data (746) 746
female (707) 707
env gene products, human immunodeficiency virus - immunology (705) 705
hiv infections - immunology (690) 690
virus diseases (671) 671
hiv infections - virology (628) 628
env gene products, human immunodeficiency virus - genetics (584) 584
aids vaccines - immunology (582) 582
amino acid sequence (576) 576
infection (553) 553
gene products, env - genetics (541) 541
human-immunodeficiency-virus (524) 524
hiv antibodies - immunology (521) 521
male (502) 502
immunodeficiency-virus type-1 (497) 497
hiv-1 (482) 482
mice (457) 457
aids (429) 429
cell line (429) 429
human immunodeficiency virus--hiv (423) 423
antibodies (419) 419
vaccines (399) 399
neutralization tests (394) 394
research (376) 376
immunization (359) 359
adult (355) 355
antibodies, neutralizing - immunology (347) 347
microbiology (345) 345
proteins (337) 337
research article (331) 331
human immunodeficiency virus (321) 321
hiv antibodies - blood (310) 310
hiv envelope protein gp120 - immunology (310) 310
phylogeny (307) 307
neutralizing antibodies (301) 301
hiv-1 - physiology (298) 298
multidisciplinary sciences (288) 288
infections (283) 283
aids vaccines (280) 280
vaccination (279) 279
hiv envelope protein gp160 (276) 276
gp120 (275) 275
health aspects (274) 274
hiv-1 - classification (264) 264
hiv infections - prevention & control (256) 256
gene products, env - metabolism (255) 255
type-1 (252) 252
macaca mulatta (251) 251
hiv infection (250) 250
vaccine (248) 248
epitopes - immunology (246) 246
hiv-1 - isolation & purification (245) 245
env gene products, human immunodeficiency virus - metabolism (244) 244
acquired immune deficiency syndrome--aids (238) 238
protein precursors - immunology (236) 236
mutation (235) 235
base sequence (232) 232
env gene products, human immunodeficiency virus (232) 232
simian immunodeficiency virus - immunology (231) 231
envelope glycoprotein (230) 230
glycoproteins (220) 220
enzyme-linked immunosorbent assay (218) 218
analysis (217) 217
gene products, gag - immunology (216) 216
mice, inbred balb c (215) 215
viral load (210) 210
env gene products, human immunodeficiency virus - chemistry (208) 208
antigens (206) 206
sequence analysis, dna (205) 205
cd4-positive t-lymphocytes - immunology (204) 204
middle aged (203) 203
medicine (200) 200
epitopes (199) 199
monoclonal-antibodies (199) 199
genetic variation (194) 194
hiv-1 - metabolism (193) 193
t-lymphocytes, cytotoxic - immunology (192) 192
aids vaccines - administration & dosage (190) 190
medicine, research & experimental (190) 190
gene products, env - chemistry (189) 189
immune response (189) 189
biology (188) 188
hiv antigens - immunology (187) 187
neutralization (186) 186
genetic aspects (182) 182
physiological aspects (182) 182
science (182) 182
virus replication (179) 179
antibodies, monoclonal - immunology (177) 177
protein (176) 176
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 8, p. e21225
Background: The safety and immunogenicity of a vaccine regimen consisting of a 6-plasmid HIV-1 DNA prime (envA, envB, envC, gagB, polB, nefB) boosted by a... 
RESPONSES | IMMUNITY | ASSAY | SAFETY | MULTIDISCIPLINARY SCIENCES | ANTIBODY | IMMUNOGENICITY EVALUATION | CANDIDATE | INFECTION | STEP | MEMORY T-CELLS | env Gene Products, Human Immunodeficiency Virus - immunology | Immunization, Secondary - adverse effects | Immunoglobulin G - blood | Human Immunodeficiency Virus Proteins - immunology | Humans | Middle Aged | AIDS Vaccines - immunology | Vaccines, DNA - immunology | pol Gene Products, Human Immunodeficiency Virus - immunology | Male | Antibodies, Viral - blood | Vaccines, DNA - administration & dosage | Young Adult | env Gene Products, Human Immunodeficiency Virus - genetics | T-Lymphocytes - metabolism | Immunoglobulin G - immunology | Adenoviridae - genetics | Adult | Female | gag Gene Products, Human Immunodeficiency Virus - genetics | pol Gene Products, Human Immunodeficiency Virus - genetics | Immunization - adverse effects | Enzyme-Linked Immunosorbent Assay | Immunization - methods | Anemia - chemically induced | Immunization, Secondary - methods | HIV-1 - genetics | HIV-1 - immunology | nef Gene Products, Human Immunodeficiency Virus - genetics | nef Gene Products, Human Immunodeficiency Virus - immunology | Interferon-gamma - immunology | Adolescent | Antibodies, Viral - immunology | Human Immunodeficiency Virus Proteins - genetics | T-Lymphocytes - immunology | AIDS Vaccines - administration & dosage | gag Gene Products, Human Immunodeficiency Virus - immunology | Interferon-gamma - blood | Cohort Studies | Oligomers | AIDS vaccines | Adenoviruses | Immunotherapy | DNA | Clinical trials | Product development | Interferon | Biological response modifiers | T cells | HIV (Viruses) | Antigenic determinants | Health care | CD8 antigen | Antibodies | Lymphocytes T | Infections | Vaccines | Epidemiology | Randomization | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Inserts | Deoxyribonucleic acid--DNA | Enzyme-linked immunosorbent assay | Binding | Medical research | Immunoglobulins | Cytokines | Epitopes | Immune response (humoral) | CD4 antigen | Disease prevention | Hospitals | Infectious diseases | Immunogenicity | γ-Interferon | Adults | Cancer | Acquired immune deficiency syndrome | Deoxyribonucleic acid | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal of Virology, ISSN 0022-538X, 03/2014, Volume 88, Issue 5, pp. 2633 - 2644
Classifications Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
HTLV-III | VIROLOGY | GP120 INNER DOMAIN | TRANSMEMBRANE GLYCOPROTEIN | EFFECTOR FUNCTION | IMMUNODEFICIENCY-VIRUS TYPE-1 | VPU PROTEIN | CONFORMATIONAL TRANSITIONS | VACCINE EFFICACY TRIAL | AIDS PATIENTS | DISEASE PROGRESSION | env Gene Products, Human Immunodeficiency Virus - immunology | Human Immunodeficiency Virus Proteins - immunology | Humans | Protein Multimerization | Antibody-Dependent Cell Cytotoxicity - immunology | env Gene Products, Human Immunodeficiency Virus - metabolism | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | HIV Antibodies - immunology | nef Gene Products, Human Immunodeficiency Virus - metabolism | Protein Interaction Domains and Motifs | Epitopes, T-Lymphocyte - immunology | CD4-Positive T-Lymphocytes - virology | env Gene Products, Human Immunodeficiency Virus - chemistry | HIV Antibodies - metabolism | CD4 Antigens - immunology | Cell Line | Viral Regulatory and Accessory Proteins - immunology | Models, Molecular | Protein Binding - immunology | Viral Regulatory and Accessory Proteins - metabolism | Human Immunodeficiency Virus Proteins - metabolism | HIV-1 - immunology | CD4 Antigens - chemistry | nef Gene Products, Human Immunodeficiency Virus - immunology | Protein Conformation | Epitopes, T-Lymphocyte - metabolism | CD4 Antigens - metabolism | HIV Infections - metabolism | Pathogenesis and Immunity
Journal Article
Nature Medicine, ISSN 1078-8956, 01/2007, Volume 13, Issue 1, pp. 100 - 106
Journal Article
PloS one, ISSN 1932-6203, 2011, Volume 6, Issue 8, p. e23293
.... In this study, we used the HIV and human interactome databases to identify HIV targeted host hub proteins and their host binding partners (H2... 
REPLICATION | PHOSPHORYLATION | TAT | MULTIDISCIPLINARY SCIENCES | KINASE | IMMUNODEFICIENCY-VIRUS TYPE-1 | SH3 DOMAINS | SHORT LINEAR MOTIFS | BINDING | VIRAL-INFECTION | NEF | rev Gene Products, Human Immunodeficiency Virus - chemistry | Humans | env Gene Products, Human Immunodeficiency Virus - metabolism | rev Gene Products, Human Immunodeficiency Virus - metabolism | nef Gene Products, Human Immunodeficiency Virus - chemistry | tat Gene Products, Human Immunodeficiency Virus - chemistry | CREB-Binding Protein - metabolism | gag Gene Products, Human Immunodeficiency Virus - metabolism | env Gene Products, Human Immunodeficiency Virus - genetics | Human Immunodeficiency Virus Proteins - chemistry | Databases, Protein | nef Gene Products, Human Immunodeficiency Virus - metabolism | gag Gene Products, Human Immunodeficiency Virus - genetics | env Gene Products, Human Immunodeficiency Virus - chemistry | Protein Structure, Tertiary | Amino Acid Sequence | Calmodulin - metabolism | Protein Structure, Secondary | tat Gene Products, Human Immunodeficiency Virus - genetics | Models, Molecular | gag Gene Products, Human Immunodeficiency Virus - chemistry | Binding Sites - genetics | Human Immunodeficiency Virus Proteins - metabolism | Proteins - genetics | Protein Interaction Mapping - methods | Proteins - metabolism | nef Gene Products, Human Immunodeficiency Virus - genetics | Hydrophobic and Hydrophilic Interactions | Protein Binding | Human Immunodeficiency Virus Proteins - genetics | rev Gene Products, Human Immunodeficiency Virus - genetics | Amino Acid Motifs - genetics | Calcium-Calmodulin-Dependent Protein Kinases - metabolism | Casein Kinase II - metabolism | Mitogen-Activated Protein Kinase 1 - metabolism | tat Gene Products, Human Immunodeficiency Virus - metabolism | Physiological aspects | Viral proteins | HIV (Viruses) | Genomics | Protein binding | Phenotypes | Phosphorylation | Hot spots | Crosstalk | Amino acid sequence | Viruses | Genomes | Kinases | Proteins | Conserved sequence | Algorithms | Human immunodeficiency virus--HIV | Computer applications | Mutation | Proteomes | Localization | Bioinformatics | Binding sites | HIV | Human immunodeficiency virus
Journal Article
PLoS ONE, ISSN 1932-6203, 2012, Volume 7, Issue 4, p. e34723
.... Subtle modifications were introduced into the GPN gene to increase Gag expression, modify the expression ratio of Gag to PolNef and support budding of virus-like particles. I. m... 
AIDS RESEARCH | IMMUNIZATION | T-CELL RESPONSES | VIRUS | PHASE-I TRIAL | IMMUNE-RESPONSES | BIOLOGY | ENVELOPE PROTEIN | INFECTION | NYVAC-C | EXPRESSION | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | Vaccines, DNA - immunology | pol Gene Products, Human Immunodeficiency Virus - immunology | Vaccines, Synthetic - immunology | Vaccines, DNA - administration & dosage | Clinical Trials, Phase III as Topic | env Gene Products, Human Immunodeficiency Virus - genetics | pol Gene Products, Human Immunodeficiency Virus - biosynthesis | HEK293 Cells | Female | pol Gene Products, Human Immunodeficiency Virus - genetics | Gene Products, gag - immunology | Gene Products, gag - genetics | Vaccines, Synthetic - genetics | nef Gene Products, Human Immunodeficiency Virus - biosynthesis | HIV-1 - genetics | Gene Products, gag - biosynthesis | HIV-1 - immunology | Animals | env Gene Products, Human Immunodeficiency Virus - biosynthesis | nef Gene Products, Human Immunodeficiency Virus - genetics | nef Gene Products, Human Immunodeficiency Virus - immunology | Vaccines, Virus-Like Particle - immunology | Mice | Mice, Inbred BALB C | Vaccines, Synthetic - administration & dosage | AIDS vaccines | Viral proteins | Vaccination | DNA | Amino acids | T cells | HIV (Viruses) | Antigenic determinants | Competition | CD8 antigen | Clinical trials | Viruses | Lymphocytes T | DNA vaccines | Histocompatibility antigen H-2 | Vaccines | Virus-like particles | Proteins | Clonal deletion | Gag protein | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Human immunodeficiency virus--HIV | Combined vaccines | Deoxyribonucleic acid--DNA | Medical research | Cytomegalovirus | Envelope protein | Gene expression | Nef protein | Immunogenicity | γ-Interferon | Budding | Acquired immune deficiency syndrome | Deoxyribonucleic acid | AIDS | HIV | Human immunodeficiency virus
Journal Article
Nature (London), ISSN 1476-4687, 2011, Volume 476, Issue 7358, pp. 96 - 100
... and inhibitory killer immunoglobulin-like receptors (KIRs)(4-7). However, it remains unknown whether NK cells can directly mediate antiviral immune pressure in vivo in humans... 
MHC CLASS-I | RESPONSES | NATURAL-KILLER-CELLS | RECOGNITION | MULTIDISCIPLINARY SCIENCES | IMMUNODEFICIENCY-VIRUS TYPE-1 | HLA-B | INHIBITORY RECEPTOR | BINDING-SITE | KIR3DL1 | VIRAL PEPTIDES | env Gene Products, Human Immunodeficiency Virus - immunology | Human Immunodeficiency Virus Proteins - immunology | Humans | env Gene Products, Human Immunodeficiency Virus - metabolism | Host-Pathogen Interactions - immunology | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Antibodies, Neutralizing - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | HIV-1 - physiology | Receptors, KIR2DL2 - genetics | Adaptation, Physiological - genetics | Receptors, KIR - metabolism | Receptors, KIR2DL2 - deficiency | Killer Cells, Natural - immunology | CD4-Positive T-Lymphocytes - virology | Receptors, KIR - deficiency | Receptors, KIR - genetics | Receptors, KIR2DL2 - immunology | Viral Regulatory and Accessory Proteins - immunology | HIV Infections - virology | Receptors, KIR2DL2 - chemistry | Viral Regulatory and Accessory Proteins - genetics | Genotype | HIV-1 - genetics | Viral Regulatory and Accessory Proteins - metabolism | Polymorphism, Genetic | Human Immunodeficiency Virus Proteins - metabolism | Adaptation, Physiological - immunology | HIV-1 - immunology | Virus Replication | Human Immunodeficiency Virus Proteins - genetics | Decision Trees | Immune Evasion - immunology | Receptors, KIR - immunology | Evolution, Molecular | Killer cells | Immune response | Management | Research | Observations | HIV infection | Hepatitis | Viruses | Immunology | Acids | Multivariate analysis | Viral infections
Journal Article
PloS one, ISSN 1932-6203, 2012, Volume 7, Issue 11, p. e48781
... protein prevents in monkeys virus spread from the portal of entry to regional lymph nodes... 
KAPOSIS-SARCOMA | GP120 CORE | MULTIDISCIPLINARY SCIENCES | PARTIAL DELETION | IMMUNODEFICIENCY-VIRUS TYPE-1 | FIBROBLAST-GROWTH-FACTOR | CYNOMOLGUS MONKEYS | ENVELOPE PROTEIN | PROTEIN-PROTEIN DOCKING | THERAPEUTIC VACCINES | STRUCTURAL CHARACTERIZATION | HIV Infections - prevention & control | Protein Interaction Domains and Motifs - immunology | env Gene Products, Human Immunodeficiency Virus - immunology | Dendritic Cells - immunology | Humans | AIDS Vaccines - immunology | Antibodies, Neutralizing - metabolism | Macaca fascicularis | Male | Neutralization Tests | env Gene Products, Human Immunodeficiency Virus - metabolism | HIV Envelope Protein gp120 - metabolism | Integrins - metabolism | T-Lymphocytes - virology | Virus Internalization | tat Gene Products, Human Immunodeficiency Virus - chemistry | HIV Envelope Protein gp120 - immunology | Recombinant Proteins - isolation & purification | HIV Infections - immunology | Antibodies, Neutralizing - immunology | Receptors, CCR5 - metabolism | HIV Antibodies - immunology | T-Lymphocytes - metabolism | HIV Infections - transmission | tat Gene Products, Human Immunodeficiency Virus - immunology | Dendritic Cells - virology | Binding Sites | env Gene Products, Human Immunodeficiency Virus - chemistry | HIV Antibodies - metabolism | Recombinant Proteins - metabolism | HIV-1 - metabolism | HIV Infections - virology | Integrins - immunology | Oligopeptides - metabolism | Receptors, CXCR4 - metabolism | HIV-1 - immunology | Vaccines, Virus-Like Particle - administration & dosage | Animals | Recombinant Proteins - immunology | Virus Replication | Protein Binding | T-Lymphocytes - immunology | Vaccines, Virus-Like Particle - immunology | Molecular Docking Simulation | AIDS Vaccines - administration & dosage | tat Gene Products, Human Immunodeficiency Virus - metabolism | Infection | AIDS vaccines | Disease transmission | HIV antibodies | Dendritic cells | Vaccination | T cells | HIV (Viruses) | Health aspects | Marburg virus disease | Integrins | Binding | CCR5 protein | Therapeutic applications | Antibodies | Envelope protein | Viruses | Lymphocytes T | Monkeys | Infections | Vaccines | Epitopes | Biological activity | Lymph nodes | Spikes | Tat protein | Clonal deletion | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Prevention programs | Human immunodeficiency virus--HIV | Neutralization | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
PLoS Pathogens, ISSN 1553-7366, 07/2017, Volume 13, Issue 7, p. e1006529
...) regimen expressing the following simian immunodeficiency virus (SIV) genes: env, gag, vif, rev, tat, and nef (Group 1... 
PROTECTION | CORRELATES ANALYSIS | MICROBIOLOGY | T-CELL RESPONSES | HIGHLY PATHOGENIC SIV | VIROLOGY | HIV | ENVELOPE | INFECTED-CELLS | VESICULAR STOMATITIS-VIRUS | DISCORDANT ASSOCIATIONS | NEUTRALIZATION | PARASITOLOGY | env Gene Products, Human Immunodeficiency Virus - immunology | SAIDS Vaccines - administration & dosage | HIV Infections - virology | Humans | Macaca mulatta | Rectum - immunology | HIV-1 - genetics | Rectum - virology | HIV Infections - immunology | SAIDS Vaccines - genetics | HIV-1 - immunology | Simian Acquired Immunodeficiency Syndrome - virology | Simian Immunodeficiency Virus - genetics | env Gene Products, Human Immunodeficiency Virus - genetics | Animals | HIV-1 - physiology | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Virus Replication | Antibodies, Viral - immunology | gag Gene Products, Human Immunodeficiency Virus - genetics | gag Gene Products, Human Immunodeficiency Virus - immunology | Disease Models, Animal | Simian Immunodeficiency Virus - immunology | Rhesus monkey | Control | AIDS vaccines | Usage | Immune response | Genetic aspects | Research | Simian immunodeficiency virus | Laboratories | Viremia | Funding | Chronic infection | Viruses | Infections | Vaccines | Loads (forces) | Proteins | Immunology | Gag protein | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Primates | Inserts | Localization | Supervision | Immune system | Antigens | Medical research | Statistical analysis | Stability | Monkeys & apes | Pathology | Tat protein | Nef protein | Replication | Neutralization | Acquired immune deficiency syndrome | AIDS | Human immunodeficiency virus
Journal Article
The Journal of Immunology, ISSN 0022-1767, 03/2009, Volume 182, Issue 6, pp. 3718 - 3727
Previously, chronic-phase protection against SHIV89.6P challenge was significantly greater in macaques primed with replicating adenovirus type 5 host range... 
DEPENDENT CELLULAR CYTOTOXICITY | MEDIATED CYTOTOXICITY | CYTO-TOXICITY | NEF PROTEIN | HIV-1 TAT PROTEIN | DIFFERENT CLINICAL STAGES | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | T-CELLS | PASSIVE-IMMUNIZATION | DISEASE PROGRESSION | Vaccines, DNA - genetics | env Gene Products, Human Immunodeficiency Virus - immunology | Antiviral Agents - immunology | Humans | Vaccines, DNA - immunology | Antibody-Dependent Cell Cytotoxicity - immunology | Male | Neutralization Tests | Macaca mulatta | Vaccines, DNA - administration & dosage | Vaccinia virus - genetics | Vaccinia virus - immunology | Simian Acquired Immunodeficiency Syndrome - virology | env Gene Products, Human Immunodeficiency Virus - genetics | Adenoviridae - genetics | Female | tat Gene Products, Human Immunodeficiency Virus - immunology | Adenoviridae - immunology | Antibodies, Viral - biosynthesis | tat Gene Products, Human Immunodeficiency Virus - administration & dosage | Antibody-Dependent Cell Cytotoxicity - genetics | Binding Sites, Antibody - genetics | SAIDS Vaccines - administration & dosage | tat Gene Products, Human Immunodeficiency Virus - genetics | Cells, Cultured | Antiviral Agents - administration & dosage | Simian Acquired Immunodeficiency Syndrome - prevention & control | Antibodies, Viral - physiology | SAIDS Vaccines - genetics | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | env Gene Products, Human Immunodeficiency Virus - administration & dosage | Cell Line, Transformed
Journal Article